Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

BCDAW

BioCardia (BCDAW)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BCDAW
DataOraFonteTitoloSimboloCompagnia
17/06/202413:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCDAWBioCardia Inc
10/06/202422:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDAWBioCardia Inc
14/05/202422:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCDAWBioCardia Inc
17/12/202014:30GlobeNewswire Inc.BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Des...NASDAQ:BCDAWBioCardia Inc
10/11/202013:00GlobeNewswire Inc.BioCardia Reports Third Quarter 2020 Financial Results and Business HighlightsNASDAQ:BCDAWBioCardia Inc
26/10/202012:30GlobeNewswire Inc.Published Peer-reviewed Initial Data from BioCardia Pivotal Phase 3 Clinical Trial of CardiAMP Demonstrates Improvement in He...NASDAQ:BCDAWBioCardia Inc
29/09/202014:00GlobeNewswire Inc.BioCardia Issued New Patent for Delivery of Cardiac Cell Therapy Through Wrist ArteryNASDAQ:BCDAWBioCardia Inc
26/08/202013:00GlobeNewswire Inc.BioCardia to Present at the LD Micro 500 Virtual Conference on September 1, 2020NASDAQ:BCDAWBioCardia Inc
13/08/202013:00GlobeNewswire Inc.BioCardia Reports Second Quarter 2020 Financial Results and Business HighlightsNASDAQ:BCDAWBioCardia Inc
07/08/202014:00GlobeNewswire Inc.BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020NASDAQ:BCDAWBioCardia Inc
01/07/202016:20GlobeNewswire Inc.BioCardia Announces Activation of Pivotal Trial Studying CardiAMP Cell Therapy Trial to Treat Chronic Myocardial IschemiaNASDAQ:BCDAWBioCardia Inc
01/07/202014:00GlobeNewswire Inc.BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 EraNASDAQ:BCDAWBioCardia Inc
17/06/202014:30GlobeNewswire Inc.BioCardia Announces Pricing of $10 Million Public OfferingNASDAQ:BCDAWBioCardia Inc
08/06/202013:31Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:BCDAWBioCardia Inc
26/05/202012:02Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:BCDAWBioCardia Inc
15/05/202014:00GlobeNewswire Inc.BioCardia Reports First Quarter 2020 Financial Results and Business HighlightsNASDAQ:BCDAWBioCardia Inc
15/05/202013:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BCDAWBioCardia Inc
08/05/202012:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCDAWBioCardia Inc
05/05/202013:00GlobeNewswire Inc.BioCardia Announces Positive Preclinical Results Supporting Investigational New Drug Application for Anti-Inflammatory Cell T...NASDAQ:BCDAWBioCardia Inc
30/04/202014:00GlobeNewswire Inc.Biocardia Announces FDA-Recommended Modifications to Primary Endpoint for Cardiamp Cell Therapy Heart Failure Trial to Suppor...NASDAQ:BCDAWBioCardia Inc
29/04/202016:37Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:BCDAWBioCardia Inc
29/04/202001:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCDAWBioCardia Inc
28/04/202021:08GlobeNewswire Inc.BioCardia Awarded New U.S. Patent Covering Helix System for Local Biotherapeutic Delivery of Autologous and Allogenic Cells t...NASDAQ:BCDAWBioCardia Inc
22/04/202012:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BCDAWBioCardia Inc
20/04/202012:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:BCDAWBioCardia Inc
14/04/202014:00GlobeNewswire Inc.BioCardia Announces Litigation Financing in the Case Captioned Boston Scientific Corp., et al., v. BioCardia Inc.NASDAQ:BCDAWBioCardia Inc
09/04/202020:03GlobeNewswire Inc.BIOCARDIA REPORTS 2019 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTSNASDAQ:BCDAWBioCardia Inc
09/04/202019:55Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BCDAWBioCardia Inc
31/03/202022:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:BCDAWBioCardia Inc
31/03/202014:00GlobeNewswire Inc.BIOCARDIA ANNOUNCES POSITIVE DSMB RECOMMENDATION TO CONTINUE PHASE III PIVOTAL CARDIAMP HEART FAILURE STUDY, AS PLANNEDNASDAQ:BCDAWBioCardia Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BCDAW
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network